ZBIO logo

ZBIO
Zenas Biopharma Inc.

807
Mkt Cap
$1.25B
Volume
167,107.00
52W High
$44.60
52W Low
$8.91
PE Ratio
-2.18
ZBIO Fundamentals
Price
$19.15
Prev Close
$19.84
Open
$19.98
50D MA
$20.52
Beta
1.44
Avg. Volume
636,908.72
EPS (Annual)
-$8.44
P/B
3.69
Rev/Employee
$59,880.24
$1,360.92
Loading...
Loading...
News
all
press releases
Tuesday 5/19 Insider Buying Report: ZBIO, ICFI
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. On Monday, Zenas Biopharma's Chief Executive Officer, Leon O. Moulder Jr., made a...
News Placeholder
More News
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Stock Price Up 7.7% - Still a Buy?
Zenas BioPharma (NASDAQ:ZBIO) Shares Up 7.7% - Should You Buy...
News Placeholder
Thursday 4/30 Insider Buying Report: ZBIO, PDX
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. At Zenas Biopharma, a filing with the SEC revealed that on Wednesday, Chief Executi...
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Shares Gap Up on Insider Buying Activity
Zenas BioPharma (NASDAQ:ZBIO) Shares Gap Up on Insider Buying Activity...
News Placeholder
Leon Moulder, Jr. Buys 25,000 Shares of Zenas BioPharma (NASDAQ:ZBIO) Stock
Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) CEO Leon Moulder, Jr. purchased 25,000 shares of the company's stock in a transaction that occurred on Tuesday, April 28th. The shares were...
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) CEO Acquires $616,700.00 in Stock
Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) CEO Leon Moulder, Jr. bought 35,000 shares of the stock in a transaction on Wednesday, April 29th. The stock was purchased at an average cost of...
News Placeholder
Leon Moulder Jr Purchases 25,000 Shares of Zenas BioPharma (NASDAQ:ZBIO) Stock
Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) CEO Leon Moulder, Jr. purchased 25,000 shares of the stock in a transaction that occurred on Tuesday, April 28th. The shares were acquired at an...
News Placeholder
Zenas BioPharma, Inc. (NASDAQ:ZBIO) Given Average Rating of "Hold" by Analysts
Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) has been given an average rating of "Hold" by the nine brokerages that are presently covering the firm, Marketbeat reports. Two investment...
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Issues Quarterly Earnings Results
Zenas BioPharma (NASDAQ:ZBIO - Get Free Report) posted its earnings results on Monday. The company reported ($1.10) earnings per share (EPS) for the quarter...
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Shares Down 7% - Should You Sell?
Zenas BioPharma (NASDAQ:ZBIO) Shares Down 7% - Should You Sell...
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available